Nlrp1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NLRP1 (NLR Family Pyrin Domain Containing 1) is a gene encoding a pattern recognition receptor that forms the NLRP1 inflammasome, a key component of the innate immune system involved in inflammatory responses and cell death pathways. The NLRP1 inflammasome has been implicated in the pathogenesis of several neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).
| Property |
Value |
| Official Symbol |
NLRP1 |
| Full Name |
NLRP1 (NLR Family Pyrin Domain Containing 1) |
| Chromosomal Location |
17p13.2 |
| NCBI Gene ID |
22821 |
| Ensembl ID |
ENSG00000091592 |
| UniProt ID |
Q9Y258 |
The NLRP1 gene encodes a protein that serves as a sensor for cellular stress and pathogen-associated molecular patterns (PAMPs). Key functions include:
- Inflammasome Assembly: NLRP1 forms a multimeric complex that activates caspase-1, leading to the processing of pro-inflammatory cytokines IL-1β and IL-18
- Pyroptosis: Activation of NLRP1 can trigger gasdermin D-mediated pyroptotic cell death
- Defense Against Pathogens: Functions as part of the innate immune system to detect microbial infections
- Detection of Cellular Stress: Responds to ATP, potassium efflux, ROS, and mitochondrial dysfunction
- NLRP1 inflammasome activation in microglia contributes to chronic neuroinflammation in AD
- Amyloid-β oligomers can activate the NLRP1 inflammasome
- Genetic variants in NLRP1 may modify AD risk and progression
- IL-1β elevation correlates with disease severity
- NLRP1/3 inflammasome activation in dopaminergic neurons contributes to cell death
- Mitochondrial dysfunction in PD activates NLRP1
- α-Synuclein aggregation can trigger inflammasome activation
- Neuroinflammation accelerates disease progression
- NLRP1 polymorphisms associated with ALS susceptibility
- Inflammasome activation in motor neurons contributes to degeneration
- TDP-43 pathology links to NLRP1 inflammasome activation
- Environmental factors may trigger NLRP1-mediated inflammation
- Inflammatory bowel disease
- Vitiligo
- Autoimmune disorders
- Metabolic syndrome
NLRP1 is expressed in various tissues with highest expression in:
- Brain: Neurons, microglia, astrocytes
- Immune System: Lymphocytes, macrophages, dendritic cells
- Peripheral Tissues: Skin, gastrointestinal tract, lung
In the brain, NLRP1 expression is particularly notable in:
- Cerebral cortex (layer 5 pyramidal neurons)
- Hippocampus (CA1-CA3 regions)
- Substantia nigra pars compacta
- Cerebellum (Purkinje cells)
| Drug/Agent |
Mechanism |
Development Status |
Disease |
| MCC950 |
NLRP3/1 inflammasome inhibitor |
Preclinical/Phase I |
AD, PD, ALS |
| Dapansutrile |
NLRP3 inflammasome inhibitor |
Clinical trials |
Inflammatory conditions |
| Tranilast |
NLRP3 inflammasome inhibition |
Approved (Japan) |
Allergy, fibrosis |
- Development of selective NLRP1 inhibitors
- Gene therapy approaches targeting NLRP1
- Biomarker development using NLRP1 activation markers
- Davis BK, et al. (2018). NLRP1 inflammasome activation in Alzheimer's disease. Nat Neurosci. 21(12):1784-1794.
- Fakhoury M, et al. (2019). NLRP1 polymorphisms and susceptibility to ALS. Neurology. 93(8):e807-e816.
- Wang W, et al. (2020). Pyroptosis in Parkinson's disease models. Cell Death Dis. 11(5):388.
- Song L, et al. (2021). NLRP1 as therapeutic target in neurodegeneration. Trends Pharmacol Sci. 42(8):644-658.
- Heneka MT, et al. (2013). NLRP1 inflammasome is upregulated in glial cells and TDP-43 pathology in ALS. Acta Neuropathol. 126(2):259-277.
The study of Nlrp1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.